Coronavirus May Boost Policy Efforts To Enhance US Drug, Medical Supply Production
Sen. Alexander says Congress should consider options to alleviate US dependence on other countries for drug and medical supply production once the outbreak subsides.
You may also be interested in...
USP information suggests many firms in India, which is restricting exports of the antibiotic, as well as China, produce it for the US market.
Dietmar Hopp, 80% shareholder of German mRNA company CureVac, has rejected the possibility that the company would sign an exclusive deal with the US for its investigational coronavirus vaccine.
Some transitional arrangements may help Indian drug firms process export obligations already underway prior to recent government restrictions designed to safeguard domestic supplies against the backdrop of supply chain stress due to the coronavirus outbreak. But will the Indian government tweak the restrictions to balance home demands and exports?